In-hospital outcome of patients with acute myocardial infarction treated by immediate angioplasty with and without cardiogenic shock. Analysis from ZABRZE Registry;Porównanie wyników leczenia chorych z niepowikłanym zawałem serca oraz zawałem z obecnościa̧ wstrza̧su kardiogennego, leczonych angioplastyka̧ wieńcowa̧. Analiza z Rejestru ZABRZE

Folia Cardiologica

Volumn 9, Issue 5, 2002, Pages 425-433

  Ga̧sior, Mariusz ^a   Zȩbik, Tadeusz ^a   Wasilewski, Jarosław ^a   Lekston, Andrzej ^a   Gierlotka, Marek ^a   Szkodzińska, Janusz ^a   Kondys, Marek ^a   Wilczek, Krzysztof ^a   Wojnar, Rafał ^a   Wnȩk, Andrzej ^a   Piegza, Jacek ^a   Dyrbuś, Krzysztof ^a   Szyguła, Bozena ^a   Pacholewicz, Jerzy ^b   Zembala, Marian ^b   Poloński, Lech ^a  

^a Slakiej Akademii Medycznej   (Poland)

^b Transplantol Slaskiej Akademii Med   (Poland)

Author keywords

Acute myocardial infarction; Cardiogenic shock; Coronary angioplasty

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; CARDIOGENIC SHOCK; CAUSE OF DEATH; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DATA ANALYSIS; DISEASE COURSE; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; REGISTER; RISK FACTOR; STATISTICAL ANALYSIS; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 0036453987     PISSN: 15074145     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. The GUSTO Angiographic Investigator. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after myocardial infarction. N. Engl. J. Med. 1993; 329: 1615-1621.
2. Hochman J.S., Boland J., Sleeper L.A. i wsp. Current spectrum of cardiogenic shok and effect of early revascularization on mortality: Results of an International Registry: SHOCK Registry Investigator. Circulation 1995; 91: 873.
3. Page D.L., Caulfield J.B., Kastor J.A., DeSanctis R.W., Sanders C.A. Myocardial changes associated with cardiogenic shock. N. Engl. Med. 1971; 285: 133.
4. Griffith G.C., Wallace W.B., Cochran B. The treatment of shock associated with myocardial infarction. Circulation 1954; 9: 527-532.
5. Goldberg R.J., Gore J.M., Alpert J.S. i wsp. Cardiogenic schock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975-1988. N. Engl. J. Med. 1991; 325: 1117-1122
6. Hochman J.S., Buller C.E., Sleeper L.A. Cardiogenic shock complicating acute myocardial infarction: Results of the SHOCK Trial Registry. J. Am. Coll. Cardiol. 2000; 36 (supl. A): 1063-1070.
7. Hochman J.S. Emergency revascularization vs initial medical stabilization for AMI with shock. SHOCK trial. JAMA 2001; 285: 190-192.
8. Dole W.P., O'Rourke R.A. Patophysiology and management of cardiogenic shock. Curr. Probl. Cardiol. 1983; 8: 1-72
9. Hands M.E., Rutherford J.D., Muller J.E. The In-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of occurrence, outcome and prognostic factors. J. Am. Coll. Cardiol. 1989; 14: 40-46
10. Bates E.R., Topol E.J. Limitation of trombolytic therapy for acute myocardial infarction complicated by congestive heart failure and cardiogenic shock. J. Am. Coll. Cardiol. 1991; 18: 1077-1084
11. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarcto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1: 397-401
12. Pluta W., Krupa H., Kalarus Z. Ostry zawal serca ze wstrza̧sem - tromboliza dowieńcowa. Kardiol. Pol. 1993; 39: 341-314.
13. Kennedy J.W., Gensini G.G., Timmis G.C., Maynard C. Acute myocardial infarction treated with intracoronary streptokinase: a report of the Society for Cardiac Angiography. Am. J. Cardiol. 1985; 55: 871-875.
14. Rewilcox R.G., Ollson C.G., Skene A.M. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Trombolysis (ASSET). Lancet 1988; 2: 525-533.
15. Camberlain D.A. Effect of intravenous APSAC on mortality after acute myocardial infarction, preliminary report of placebo-control clinical trial. AIMS trial study group. Lancet 1988; 1: 545-549.
16. O'Neill W., Topol E., George B. Improvement in left ventricular function after thrombolytic therapy and angioplasty; results of the TAMI study. Circulation 1987; 76 (supl. IV): IV-259 (streszczenie).
17. Lee L., Bates E.R., Pitt B., Walton J.A., Laufer N., O'Neill W.W. Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock. Circulation 1988; 78: 1345-1351
18. Shani J., Riviera M., Greengart A. Percutaneous transluminal coronary angioplasty in cardiogenic shock. J. Am. Coll. Cardiol. 1987; 7: 149A (streszczenie).
19. Brodie B.R., Weintraub R.A., Stuckey T.D. i wsp. Outcomes of direct coronary angioplasty for thrombolytic therapy. Am. J. Cardiol. 1991; 67: 7-12.
20. Moosvi A.R., Khaja F., Villanueva L., Gheorghiade M., Douthat L., Goldstein S. Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarction. J. Am. Coll. Cardiol. 1992; 19: 907-914.
21. O'Neill W. Angioplasty therapy of cardiogenic Shock: Are randomized trials necessary? J. Am. Coll. Cardiol. 1992. (strony?tom?)
22. Webb J.G., Carere R.G., Hilton J.D. i wsp. Percutaneous coronary intervention for cardiogenic shock in the Shock Trial Registry. Am. Heart J. 2001; 141: 964-970.
23. Lee L., Erbel R., Brown T.M. Multicenter registry of angioplasty therapy of cardiogenic shock: initial and long-therm survival. J. Am. Coll. Cardiol. 1991; 17: 599-560.
24. Morrison D., Crowley S.T., Bies R. Systolic blood pressure response to percutaneous transluminal coronary angioplasty for cardiogenic shock. Am. J. Cardiol. 1995; 76: 313-314.
25. Stomel R.J., Rask M., Bates E.R. Treatment strategies for acute myocardial infarction complicated by cardiogenic shock in community hospital. Chest 1994; 105: 997.
26. Goldberg M., Tabak S.W., Preiman S.K. Clinical experience with intra-aortic balloon pump counterpulsation in 112 consecutive patients. Am. Heart J. 1986; 3: 497-502.
27. Gurbel P.A., Anderson R.D., MacCord C.S. Arterial diastolic pressure augmentation by intraaortic ballon counterpulsation enhances the onset of coronary artery reperfusion by thrombolytic therapy. Circulation 1994; 89: 361-365.
28. Prewitt R.M., Gu S., Schick U. Intraaortic balloon counterpulsation enhances coronary thrombolysis induced by intravenous administration of a thrombolytic agent. J. Am. Coll. Cardiol. 1994; 23: 794-798.
29. Ohman E.M., George B.S., White C.J. Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. Circulation 1994; 90: 792-799.
30. DeWood M.A., Notske R.N., Hensley G.R. i wsp. Intra-aortic balloon counterpulsation with and without reperfusion for myocardial infarction shock. Circulation 1980; 61: 1105-1112